United States Biotechnology & Medical Research

Track

Werewolf Therapeutics Inc (HOWL)

Track

Over the past 90 days, Werewolf Therapeutics Inc. has seen significant insider selling, with 115 transactions totaling approximately $1.36 million in net value. Major shareholders, including various MPM entities and Luke Evnin, have executed numerous planned and proposed sales. These divestments occur amid a 57.8% decline in stock price over the same period.

Active selling signal · Exceptional

Top insider sells (90, 60d)

Featured in screeners

Active selling signal · Exceptional

Top insider sells

Ticker: HOWL Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

2 activity signals detected for Werewolf Therapeutics Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Werewolf Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results Settings

Trades

EVNIN LUKE

1 sale — total 100,000 USD

Planned sale 7 Jul 2026

Value US$4,337,834.13 | Price 67.35 | Shares 47,445

EVNIN LUKE

1 sale — total 100,000 USD

Planned sale 6 Jul 2026

Value US$2,059,515.40 | Price 184.28 | Shares 26,017

UBS Oncology Impact Fund, L.P.

Shareholder

1 sale — total 100,000 USD

Proposed sale 6 Jul 2026

Value US$100,000.00 | Price 0.34 | Shares 1,000

MPM Asset Management LLC

Shareholder

1 sale — total 100,000 USD

Proposed sale 6 Jul 2026

Value US$100,000.00 | Price 0.34 | Shares 1,000

MPM Asset Management Investors BV2014 LLC

Shareholder

1 sale — total 100,000 USD

Proposed sale 6 Jul 2026

Value US$100,000.00 | Price 0.34 | Shares 1,000

MPM BioVentures 2014 (B), L.P.

Shareholder

1 sale — total 100,000 USD

Proposed sale 6 Jul 2026

Value US$100,000.00 | Price 0.34 | Shares 1,000

MPM Oncology Innovations Fund, L.P.

Shareholder

1 sale — total 100,000 USD

Proposed sale 6 Jul 2026

Value US$100,000.00 | Price 0.34 | Shares 1,000

MPM BioVentures 2014, L.P.

Shareholder

1 sale — total 100,000 USD

Proposed sale 6 Jul 2026

Value US$100,000.00 | Price 0.34 | Shares 1,000

EVNIN LUKE

1 sale — total 47,125 USD

Planned sale 29 Jun 2026

Value US$47,125.20 | Price 0.30 | Shares 157,084

MPM Asset Management Investors BV2014 LLC

Shareholder

1 sale — total 1,181 USD

Proposed sale 29 Jun 2026

Value US$1,181.21 | Price 0.32 | Shares 3,657

MPM Asset Management LLC

Shareholder

1 sale — total 5,436 USD

Proposed sale 29 Jun 2026

Value US$5,436.09 | Price 0.32 | Shares 16,830

MPM Oncology Innovations Fund, L.P.

Shareholder

1 sale — total 7,509 USD

Proposed sale 29 Jun 2026

Value US$7,509.10 | Price 0.32 | Shares 23,248

MPM BioVentures 2014, L.P.

Shareholder

1 sale — total 34,323 USD

Proposed sale 29 Jun 2026

Value US$34,322.63 | Price 0.32 | Shares 106,262

MPM BioVentures 2014 (B), L.P.

Shareholder

1 sale — total 2,289 USD

Proposed sale 29 Jun 2026

Value US$2,289.10 | Price 0.32 | Shares 7,087

UBS Oncology Impact Fund, L.P.

Shareholder

1 sale — total 28,397 USD

Proposed sale 29 Jun 2026

Value US$28,396.87 | Price 0.32 | Shares 87,916

RA CAPITAL MANAGEMENT, L.P.

4 sales — total 291,838 USD

Sale 17 Jun 2026

Value US$9,693.25 | Price 0.35 | Shares 27,695

Sale 17 Jun 2026

Value US$9,693.25 | Price 0.35 | Shares 27,695

Sale 17 Jun 2026

Value US$136,225.60 | Price 0.35 | Shares 389,216

Sale 17 Jun 2026

Value US$136,225.60 | Price 0.35 | Shares 389,216

RA CAPITAL MANAGEMENT, L.P.

2 sales — total 55,361 USD

Sale 16 Jun 2026

Value US$3,677.43 | Price 0.37 | Shares 9,939

Sale 16 Jun 2026

Value US$51,683.82 | Price 0.37 | Shares 139,686

RA CAPITAL MANAGEMENT, L.P.

2 sales — total 50,220 USD

Sale 15 Jun 2026

Value US$3,336.06 | Price 0.39 | Shares 8,554

Sale 15 Jun 2026

Value US$46,884.24 | Price 0.39 | Shares 120,216

RA CAPITAL MANAGEMENT, L.P.

2 sales — total 68,176 USD

Sale 12 Jun 2026

Value US$4,528.80 | Price 0.40 | Shares 11,322

Sale 12 Jun 2026

Value US$63,647.60 | Price 0.40 | Shares 159,119

RA CAPITAL MANAGEMENT, L.P.

6 sales — total 299,253 USD

Sale 11 Jun 2026

Value US$6,626.06 | Price 0.38 | Shares 17,437

Sale 11 Jun 2026

Value US$6,626.06 | Price 0.38 | Shares 17,437

Sale 11 Jun 2026

Value US$93,125.08 | Price 0.38 | Shares 245,066

Sale 11 Jun 2026

Value US$93,125.08 | Price 0.38 | Shares 245,066

Sale 11 Jun 2026

Value US$6,626.06 | Price 0.38 | Shares 17,437

Sale 11 Jun 2026

Value US$93,125.08 | Price 0.38 | Shares 245,066

RA CAPITAL MANAGEMENT, L.P.

6 sales — total 50,975 USD

Sale 10 Jun 2026

Value US$1,128.87 | Price 0.37 | Shares 3,051

Sale 10 Jun 2026

Value US$1,128.87 | Price 0.37 | Shares 3,051

Sale 10 Jun 2026

Value US$15,862.64 | Price 0.37 | Shares 42,872

Sale 10 Jun 2026

Value US$15,862.64 | Price 0.37 | Shares 42,872

Sale 10 Jun 2026

Value US$1,128.87 | Price 0.37 | Shares 3,051

Sale 10 Jun 2026

Value US$15,862.64 | Price 0.37 | Shares 42,872

RA CAPITAL MANAGEMENT, L.P.

4 sales — total 155,004 USD

Sale 9 Jun 2026

Value US$9,089.05 | Price 0.37 | Shares 24,565

Sale 9 Jun 2026

Value US$9,089.05 | Price 0.37 | Shares 24,565

Sale 9 Jun 2026

Value US$9,089.05 | Price 0.37 | Shares 24,565

Sale 9 Jun 2026

Value US$127,736.95 | Price 0.37 | Shares 345,235

EVNIN LUKE

1 sale — total 28,463 USD

Planned sale 9 Jun 2026

Value US$28,463.36 | Price 0.37 | Shares 76,928

EVNIN LUKE

1 sale — total 24,219 USD

Planned sale 8 Jun 2026

Value US$24,218.80 | Price 0.40 | Shares 60,547

EVNIN LUKE

1 sale — total 9,978 USD

Planned sale 5 Jun 2026

Value US$9,978.40 | Price 0.40 | Shares 24,946

EVNIN LUKE

1 sale — total 8,832 USD

Planned sale 4 Jun 2026

Value US$8,831.68 | Price 0.44 | Shares 20,072

EVNIN LUKE

1 sale — total 12,495 USD

Planned sale 3 Jun 2026

Value US$12,494.58 | Price 0.42 | Shares 29,749

EVNIN LUKE

1 sale — total 13,318 USD

Planned sale 2 Jun 2026

Value US$13,317.75 | Price 0.45 | Shares 29,595

EVNIN LUKE

1 sale — total 37,816 USD

Planned sale 1 Jun 2026

Value US$37,815.73 | Price 0.47 | Shares 80,459

EVNIN LUKE

1 sale — total 14,650 USD

Planned sale 29 May 2026

Value US$14,650.20 | Price 0.45 | Shares 32,556

EVNIN LUKE

1 sale — total 12,741 USD

Planned sale 28 May 2026

Value US$12,741.08 | Price 0.46 | Shares 27,698

MPM BioVentures 2014, L.P.

Shareholder

1 sale — total 119,651 USD

Proposed sale 28 May 2026

Value US$119,650.65 | Price 0.49 | Shares 244,185

MPM BioVentures 2014 (B), L.P.

Shareholder

1 sale — total 7,981 USD

Proposed sale 28 May 2026

Value US$7,980.63 | Price 0.49 | Shares 16,287

MPM Asset Management Investors BV2014 LLC

Shareholder

1 sale — total 4,118 USD

Proposed sale 28 May 2026

Value US$4,118.45 | Price 0.49 | Shares 8,405

MPM Asset Management LLC

Shareholder

1 sale — total 18,951 USD

Proposed sale 28 May 2026

Value US$18,950.75 | Price 0.49 | Shares 38,675

UBS Oncology Impact Fund, L.P.

Shareholder

1 sale — total 98,994 USD

Proposed sale 28 May 2026

Value US$98,994.21 | Price 0.49 | Shares 202,029

MPM Oncology Innovations Fund, L.P.

Shareholder

1 sale — total 26,178 USD

Proposed sale 28 May 2026

Value US$26,178.25 | Price 0.49 | Shares 53,425

EVNIN LUKE

1 sale — total 38,809 USD

Planned sale 27 May 2026

Value US$38,808.96 | Price 0.48 | Shares 80,852

EVNIN LUKE

1 sale — total 31,937 USD

Planned sale 26 May 2026

Value US$31,936.50 | Price 0.47 | Shares 67,950

EVNIN LUKE

1 sale — total 39,341 USD

Planned sale 22 May 2026

Value US$39,341.25 | Price 0.45 | Shares 87,425

EVNIN LUKE

1 sale — total 15,283 USD

Planned sale 21 May 2026

Value US$15,282.54 | Price 0.42 | Shares 36,387

EVNIN LUKE

1 sale — total 36,935 USD

Planned sale 20 May 2026

Value US$36,934.85 | Price 0.43 | Shares 85,895

EVNIN LUKE

1 sale — total 28,337 USD

Planned sale 19 May 2026

Value US$28,336.50 | Price 0.45 | Shares 62,970

EVNIN LUKE

1 sale — total 11,092 USD

Planned sale 18 May 2026

Value US$11,092.00 | Price 0.50 | Shares 22,184

UBS Oncology Impact Fund, L.P.

Shareholder

1 sale — total 123,768 USD

Proposed sale 18 May 2026

Value US$123,768.23 | Price 0.52 | Shares 240,280

MPM Oncology Innovations Fund, L.P.

Shareholder

1 sale — total 32,729 USD

Proposed sale 18 May 2026

Value US$32,729.45 | Price 0.52 | Shares 63,540

MPM BioVentures 2014 (B), L.P.

Shareholder

1 sale — total 9,977 USD

Proposed sale 18 May 2026

Value US$9,977.49 | Price 0.52 | Shares 19,370

MPM Asset Management Investors BV2014 LLC

Shareholder

1 sale — total 5,149 USD

Proposed sale 18 May 2026

Value US$5,148.94 | Price 0.52 | Shares 9,996

MPM BioVentures 2014, L.P.

Shareholder

1 sale — total 149,595 USD

Proposed sale 18 May 2026

Value US$149,594.83 | Price 0.52 | Shares 290,419

MPM Asset Management LLC

Shareholder

1 sale — total 23,694 USD

Proposed sale 18 May 2026

Value US$23,693.57 | Price 0.52 | Shares 45,998

EVNIN LUKE

1 sale — total 24,127 USD

Planned sale 13 May 2026

Value US$24,126.66 | Price 0.54 | Shares 44,679

EVNIN LUKE

1 sale — total 43,446 USD

Planned sale 12 May 2026

Value US$43,446.40 | Price 0.64 | Shares 67,885

RA CAPITAL MANAGEMENT, L.P.

2 sales — total 64,737 USD

Sale 12 May 2026

Value US$4,300.16 | Price 0.64 | Shares 6,719

Sale 12 May 2026

Value US$60,436.48 | Price 0.64 | Shares 94,432

EVNIN LUKE

1 sale — total 22,745 USD

Planned sale 11 May 2026

Value US$22,745.16 | Price 0.67 | Shares 33,948

RA CAPITAL MANAGEMENT, L.P.

1 sale — total 3,894 USD

Sale 11 May 2026

Value US$3,894.04 | Price 0.67 | Shares 5,812

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-07-08	2026-07-07	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	47,445 -45.0% 67.35 US$4,337,834	47,445 -45.0%	67.35	US$4,337,834
2026-07-08	2026-07-06	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	26,017 -43.5% 184.28 US$2,059,515	26,017 -43.5%	184.28	US$2,059,515
2026-07-06	2026-07-06	PrS Proposed sale	2.3 UBS Oncology Impact Fund, L.P. Shareholder	86,909 136.30 US$1,628,163	86,909	136.30	US$1,628,163
2026-07-06	2026-07-06	PrS Proposed sale	MPM Asset Management LLC Shareholder	1,000 0.34 US$100,000	1,000	0.34	US$100,000
2026-07-06	2026-07-06	PrS Proposed sale	MPM Asset Management Investors BV2014 LLC Shareholder	1,000 0.34 US$100,000	1,000	0.34	US$100,000
2026-07-06	2026-07-06	PrS Proposed sale	MPM BioVentures 2014 (B), L.P. Shareholder	1,000 0.34 US$100,000	1,000	0.34	US$100,000
2026-07-06	2026-07-06	PrS Proposed sale	MPM Oncology Innovations Fund, L.P. Shareholder	1,000 0.34 US$100,000	1,000	0.34	US$100,000
2026-07-06	2026-07-06	PrS Proposed sale	3.2 MPM BioVentures 2014, L.P. Shareholder	1,000 0.34 US$100,000	1,000	0.34	US$100,000
2026-06-29	2026-06-29	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	157,084 -52.3% 0.30 US$47,125	157,084 -52.3%	0.30	US$47,125
2026-06-29	2026-06-29	PrS Proposed sale	MPM Asset Management Investors BV2014 LLC Shareholder	3,657 0.32 US$1,181	3,657	0.32	US$1,181
2026-06-29	2026-06-29	PrS Proposed sale	MPM Asset Management LLC Shareholder	16,830 0.32 US$5,436	16,830	0.32	US$5,436
2026-06-29	2026-06-29	PrS Proposed sale	MPM Oncology Innovations Fund, L.P. Shareholder	23,248 0.32 US$7,509	23,248	0.32	US$7,509
2026-06-29	2026-06-29	PrS Proposed sale	3.2 MPM BioVentures 2014, L.P. Shareholder	106,262 0.32 US$34,323	106,262	0.32	US$34,323
2026-06-29	2026-06-29	PrS Proposed sale	MPM BioVentures 2014 (B), L.P. Shareholder	7,087 0.32 US$2,289	7,087	0.32	US$2,289
2026-06-29	2026-06-29	PrS Proposed sale	2.3 UBS Oncology Impact Fund, L.P. Shareholder	87,916 0.32 US$28,397	87,916	0.32	US$28,397
2026-06-22	2026-06-17	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	27,695 -8.4% 0.35 US$9,693	27,695 -8.4%	0.35	US$9,693
2026-06-22	2026-06-17	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	27,695 -8.4% 0.35 US$9,693	27,695 -8.4%	0.35	US$9,693
2026-06-22	2026-06-17	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	389,216 -8.4% 0.35 US$136,226	389,216 -8.4%	0.35	US$136,226
2026-06-22	2026-06-17	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	389,216 -8.4% 0.35 US$136,226	389,216 -8.4%	0.35	US$136,226
2026-06-16	2026-06-16	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	9,939 -2.9% 0.37 US$3,677	9,939 -2.9%	0.37	US$3,677
2026-06-16	2026-06-16	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	139,686 -2.9% 0.37 US$51,684	139,686 -2.9%	0.37	US$51,684
2026-06-16	2026-06-15	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	8,554 -2.4% 0.39 US$3,336	8,554 -2.4%	0.39	US$3,336
2026-06-16	2026-06-15	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	120,216 -2.4% 0.39 US$46,884	120,216 -2.4%	0.39	US$46,884
2026-06-16	2026-06-12	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	11,322 -3.1% 0.40 US$4,529	11,322 -3.1%	0.40	US$4,529
2026-06-16	2026-06-12	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	159,119 -3.1% 0.40 US$63,648	159,119 -3.1%	0.40	US$63,648
2026-06-11	2026-06-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	17,437 -4.6% 0.38 US$6,626	17,437 -4.6%	0.38	US$6,626
2026-06-11	2026-06-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	17,437 -4.6% 0.38 US$6,626	17,437 -4.6%	0.38	US$6,626
2026-06-11	2026-06-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	245,066 -4.6% 0.38 US$93,125	245,066 -4.6%	0.38	US$93,125
2026-06-11	2026-06-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	245,066 -4.6% 0.38 US$93,125	245,066 -4.6%	0.38	US$93,125
2026-06-11	2026-06-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	17,437 -4.6% 0.38 US$6,626	17,437 -4.6%	0.38	US$6,626
2026-06-11	2026-06-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	245,066 -4.6% 0.38 US$93,125	245,066 -4.6%	0.38	US$93,125
2026-06-11	2026-06-10	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	3,051 -0.8% 0.37 US$1,129	3,051 -0.8%	0.37	US$1,129
2026-06-11	2026-06-10	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	3,051 -0.8% 0.37 US$1,129	3,051 -0.8%	0.37	US$1,129
2026-06-11	2026-06-10	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	42,872 -0.8% 0.37 US$15,863	42,872 -0.8%	0.37	US$15,863
2026-06-11	2026-06-10	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	42,872 -0.8% 0.37 US$15,863	42,872 -0.8%	0.37	US$15,863
2026-06-11	2026-06-10	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	3,051 -0.8% 0.37 US$1,129	3,051 -0.8%	0.37	US$1,129
2026-06-11	2026-06-10	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	42,872 -0.8% 0.37 US$15,863	42,872 -0.8%	0.37	US$15,863
2026-06-11	2026-06-09	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	24,565 -6.0% 0.37 US$9,089	24,565 -6.0%	0.37	US$9,089
2026-06-11	2026-06-09	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	24,565 -6.0% 0.37 US$9,089	24,565 -6.0%	0.37	US$9,089
2026-06-11	2026-06-09	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	24,565 -6.0% 0.37 US$9,089	24,565 -6.0%	0.37	US$9,089
2026-06-11	2026-06-09	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	345,235 -6.0% 0.37 US$127,737	345,235 -6.0%	0.37	US$127,737
2026-06-10	2026-06-09	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	76,928 -20.4% 0.37 US$28,463	76,928 -20.4%	0.37	US$28,463
2026-06-08	2026-06-08	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	60,547 -13.8% 0.40 US$24,219	60,547 -13.8%	0.40	US$24,219
2026-06-08	2026-06-05	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	24,946 -5.4% 0.40 US$9,978	24,946 -5.4%	0.40	US$9,978
2026-06-08	2026-06-04	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	20,072 -4.2% 0.44 US$8,832	20,072 -4.2%	0.44	US$8,832
2026-06-03	2026-06-03	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	29,749 -5.8% 0.42 US$12,495	29,749 -5.8%	0.42	US$12,495
2026-06-03	2026-06-02	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	29,595 -5.5% 0.45 US$13,318	29,595 -5.5%	0.45	US$13,318
2026-06-03	2026-06-01	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	80,459 -12.9% 0.47 US$37,816	80,459 -12.9%	0.47	US$37,816
2026-05-29	2026-05-29	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	32,556 -5.0% 0.45 US$14,650	32,556 -5.0%	0.45	US$14,650
2026-05-29	2026-05-28	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	27,698 -4.1% 0.46 US$12,741	27,698 -4.1%	0.46	US$12,741
2026-05-28	2026-05-28	PrS Proposed sale	3.2 MPM BioVentures 2014, L.P. Shareholder	244,185 0.49 US$119,651	244,185	0.49	US$119,651
2026-05-28	2026-05-28	PrS Proposed sale	MPM BioVentures 2014 (B), L.P. Shareholder	16,287 0.49 US$7,981	16,287	0.49	US$7,981
2026-05-28	2026-05-28	PrS Proposed sale	MPM Asset Management Investors BV2014 LLC Shareholder	8,405 0.49 US$4,118	8,405	0.49	US$4,118
2026-05-28	2026-05-28	PrS Proposed sale	MPM Asset Management LLC Shareholder	38,675 0.49 US$18,951	38,675	0.49	US$18,951
2026-05-28	2026-05-28	PrS Proposed sale	2.3 UBS Oncology Impact Fund, L.P. Shareholder	202,029 0.49 US$98,994	202,029	0.49	US$98,994
2026-05-28	2026-05-28	PrS Proposed sale	MPM Oncology Innovations Fund, L.P. Shareholder	53,425 0.49 US$26,178	53,425	0.49	US$26,178
2026-05-29	2026-05-27	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	80,852 -10.6% 0.48 US$38,809	80,852 -10.6%	0.48	US$38,809
2026-05-26	2026-05-26	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	67,950 -8.2% 0.47 US$31,936	67,950 -8.2%	0.47	US$31,936
2026-05-26	2026-05-22	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	87,425 -9.5% 0.45 US$39,341	87,425 -9.5%	0.45	US$39,341
2026-05-26	2026-05-21	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	36,387 -3.8% 0.42 US$15,283	36,387 -3.8%	0.42	US$15,283
2026-05-20	2026-05-20	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	85,895 -8.2% 0.43 US$36,935	85,895 -8.2%	0.43	US$36,935
2026-05-20	2026-05-19	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	62,970 -5.7% 0.45 US$28,336	62,970 -5.7%	0.45	US$28,336
2026-05-20	2026-05-18	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	22,184 -2.0% 0.50 US$11,092	22,184 -2.0%	0.50	US$11,092
2026-05-18	2026-05-18	PrS Proposed sale	2.3 UBS Oncology Impact Fund, L.P. Shareholder	240,280 0.52 US$123,768	240,280	0.52	US$123,768
2026-05-18	2026-05-18	PrS Proposed sale	MPM Oncology Innovations Fund, L.P. Shareholder	63,540 0.52 US$32,729	63,540	0.52	US$32,729
2026-05-18	2026-05-18	PrS Proposed sale	MPM BioVentures 2014 (B), L.P. Shareholder	19,370 0.52 US$9,977	19,370	0.52	US$9,977
2026-05-18	2026-05-18	PrS Proposed sale	MPM Asset Management Investors BV2014 LLC Shareholder	9,996 0.52 US$5,149	9,996	0.52	US$5,149
2026-05-18	2026-05-18	PrS Proposed sale	3.2 MPM BioVentures 2014, L.P. Shareholder	290,419 0.52 US$149,595	290,419	0.52	US$149,595
2026-05-18	2026-05-18	PrS Proposed sale	MPM Asset Management LLC Shareholder	45,998 0.52 US$23,694	45,998	0.52	US$23,694
2026-05-13	2026-05-13	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	44,679 -3.8% 0.54 US$24,127	44,679 -3.8%	0.54	US$24,127
2026-05-12	2026-05-12	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	67,885 -5.5% 0.64 US$43,446	67,885 -5.5%	0.64	US$43,446
2026-05-12	2026-05-12	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	6,719 -1.6% 0.64 US$4,300	6,719 -1.6%	0.64	US$4,300
2026-05-12	2026-05-12	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	94,432 -1.6% 0.64 US$60,436	94,432 -1.6%	0.64	US$60,436
2026-05-12	2026-05-11	PlS Planned sale	1.8 EVNIN LUKE Non-Executive Director	33,948 -2.7% 0.67 US$22,745	33,948 -2.7%	0.67	US$22,745
2026-05-12	2026-05-11	S Sale	2.9 RA CAPITAL MANAGEMENT, L.P. Large shareholder	5,812 -1.4% 0.67 US$3,894	5,812 -1.4%	0.67	US$3,894

Explore more

More insider trading research around Werewolf Therapeutics Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America